78 related articles for article (PubMed ID: 18701844)
21. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
[TBL] [Abstract][Full Text] [Related]
23. Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
Lorizzo K; Fazio N; Radice D; Boselli S; Ariu L; Zampino MG; Nolè F; Magni E; Ardito R; Minchella I; Rocca A; Di Meglio G; Squadroni M; de Braud F
Cancer Chemother Pharmacol; 2009 Jul; 64(2):301-6. PubMed ID: 19034450
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy and safety of modified FOLFOX6 regimen in aged patients with nonresectable colorectal cancer].
Ishiguro T; Ishibashi K; Okada N; Kuwabara K; Miyazaki T; Yokoyama M; Matsuki M; Sano M; Inoue N; Ishida H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2286-8. PubMed ID: 19106598
[TBL] [Abstract][Full Text] [Related]
25. [Induced nausea and vomiting induced by mFOLFOX6 and FOLFIRI with advanced colorectal cancer: a retrospective survey].
Sato Y; Tatematsu M; Ishikawa K; Okamoto H; Muro K; Noma H
Yakugaku Zasshi; 2011; 131(11):1661-6. PubMed ID: 22041706
[TBL] [Abstract][Full Text] [Related]
26. [Effect of withdrawal of 5-fluorouracil bolus administration on recovery from neutropenia in colorectal cancer patients treated with mFOLFOX6 chemotherapy-comparison with total dosage reduction].
Ueda H; Demizu M; Oosawa M; Chihara S; Nakanishi Y; Maeda C; Yano K; Kimura F; Iwakawa S
Gan To Kagaku Ryoho; 2009 May; 36(5):789-93. PubMed ID: 19461179
[TBL] [Abstract][Full Text] [Related]
27. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage II colorectal cancer.
Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Oida Y; Nakamura M; Makuuchi H
Oncol Rep; 2008 Nov; 20(5):1189-94. PubMed ID: 18949420
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer.
Cao W; Yang W; Lou G; Jiang J; Geng M; Xi W; Li H; Ma T; Jin Y
Anticancer Drugs; 2009 Apr; 20(4):287-93. PubMed ID: 19177020
[TBL] [Abstract][Full Text] [Related]
29. [Complete response of advanced rectal cancer with combined therapy of S-1 + chemo-radiation plus FOLFIRI--a case report].
Hata T; Kagawa Y; Ikeda K; Kato H; Takamoto K; Oshima N; Maeda S; Nomura M; Hayashi S; Sasaki T; Shimizu J; Kawanishi K; Fujita J; Akagi K; Tsukahara Y; Kitada M; Shimano T
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2177-9. PubMed ID: 19106562
[TBL] [Abstract][Full Text] [Related]
30. [Pharmaceutical services for patients receiving AC chemotherapy].
Higuchi M; Matsuo K; Ureshino Y; Ogata K; Futagami K; Kitamura K; Nishino H
Gan To Kagaku Ryoho; 2009 Feb; 36(2):241-5. PubMed ID: 19223738
[TBL] [Abstract][Full Text] [Related]
31. [Management of chemotherapy induced diarrhea].
Schultz M; Schölmerich J; Kullmann F
Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
33. Variation in the cost of medications for the treatment of colorectal cancer.
Ferro SA; Myer BS; Wolff DA; Poniewierski MS; Culakova E; Cosler LE; Scarpace SL; Khorana AA; Lyman GH
Am J Manag Care; 2008 Nov; 14(11):717-25. PubMed ID: 18999906
[TBL] [Abstract][Full Text] [Related]
34. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
Seki H; Ozaki T; Shiina M
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
[TBL] [Abstract][Full Text] [Related]
35. Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy.
Aprile G; Ramoni M; Keefe D; Sonis S
Cancer; 2008 Jan; 112(2):284-92. PubMed ID: 18041060
[TBL] [Abstract][Full Text] [Related]
36. Hypomagnesemia and Chemotherapy, Diagnostic Dilemma, and Treatment Challenge: Case Report and Literature Review.
Haroon N; Raza SM; Bhat ZY
Am J Ther; 2016; 23(4):e1085-90. PubMed ID: 25461961
[TBL] [Abstract][Full Text] [Related]
37. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
Wijesinghe N
N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
[TBL] [Abstract][Full Text] [Related]
38. Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.
Farrell MP; Kummar S
Clin Colorectal Cancer; 2003 Feb; 2(4):253-6. PubMed ID: 12620148
[No Abstract] [Full Text] [Related]
39. Subcutaneous tuberculosis formation during FOLFIRI and bevacizumab treatment: a case report.
Zheng XW; Ren LL; Zhang YW; Yin WJ; Tao G; Xin WX; Chen ZJ; Huang P
Int J Colorectal Dis; 2016 Apr; 31(4):943-4. PubMed ID: 26298180
[No Abstract] [Full Text] [Related]
40. Anything in modulation?
Gray R; Hills R; Stowe R
Ann Oncol; 2003 Sep; 14(9):1338-9. PubMed ID: 12954571
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
